Latest information on COVID-19
Support teaching, research, and patient care.
Interventional neuroradiology; cerebral arteriovenous malformations; stroke treatment and imaging; cerebral aneurysms
Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke 3
This is a study to evaluate the hypothesis that FDA cleared thrombectomy devices plus medical
management leads to superior clinical outcomes in acute ischemic stroke patients at 90 days
when compared to medical management alone in appropriately selected subjects with the Target
mismatch profile and an MCA (M1 segment) or ICA occlusion who can be randomized and have
endovascular treatment initiated between 6-16 hours after last seen well.
Stanford is currently not accepting patients for this trial.
For more information, please contact SPECTRUM, .
View full details